Literature DB >> 6914299

An elastase-specific inhibitor from human bronchial mucus. Isolation and characterization.

K Hochstrasser, G J Albrecht, O L Schönberger, B Rasche, K Lempart.   

Abstract

It was shown previously that human bronchial mucus contains an acid-stable proteinase inhibitor directed against trypsin and chymotrypsin, polymorphonuclear granulocyte elastase and cathepsin G. In addition to this well-characterized inhibitor, designated here as BSI-ATE (identical with the inhibitor HUSI-I from human seminal plasma or antileucoprotease), another acid-stable inhibitor BSI-E is present in the mucus which exerts inhibitory activity towards porcine pancreatic and human granulocytic elastase, but not against trypsin, chymotrypsin, or granulocytic cathepsin G. This elastase-specific inhibitor was isolated by affinity chromatography. Its molecular mass and its amino acid composition are very similar to those of BSI-TE. An immunological cross-reactivity between both inhibitor species was not observed. In the mucus of patients suffering from obstructive airway disease the elastase-specific inhibitor is not present in the free form but can be liberated by acidification.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6914299     DOI: 10.1515/bchm2.1981.362.2.1369

Source DB:  PubMed          Journal:  Hoppe Seylers Z Physiol Chem        ISSN: 0018-4888


  8 in total

1.  In vivo effects of transient neutrophil influx on nasal respiratory epithelial mucosubstances. Quantitative histochemistry.

Authors:  J R Harkema; J A Hotchkiss; A G Harmsen; R F Henderson
Journal:  Am J Pathol       Date:  1988-03       Impact factor: 4.307

2.  Differential expression of SKALP/Elafin in human epidermal tumors.

Authors:  H A Alkemade; H O Molhuizen; I M van Vlijmen-Willems; U J van Haelst; J Schalkwijk
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

3.  Localisation of a low-molecular-weight bronchial protease inhibitor in the peripheral human lung.

Authors:  H W Mooren; J A Kramps; C Franken; C J Meijer; J A Dijkman
Journal:  Thorax       Date:  1983-03       Impact factor: 9.139

4.  Human bronchial leucocyte proteinase inhibitor. Rapid isolation and kinetic analysis with human leucocyte proteinases.

Authors:  C E Smith; D A Johnson
Journal:  Biochem J       Date:  1985-01-15       Impact factor: 3.857

5.  Inhibitory capacity of alpha 1 antitrypsin in lung secretions: variability and the effect of drugs.

Authors:  H M Morrison; S C Afford; R A Stockley
Journal:  Thorax       Date:  1984-07       Impact factor: 9.139

Review 6.  Proteases and antiproteases in chronic neutrophilic lung disease - relevance to drug discovery.

Authors:  Catherine M Greene; Noel G McElvaney
Journal:  Br J Pharmacol       Date:  2009-10       Impact factor: 8.739

Review 7.  Antimicrobial peptides in human skin disease.

Authors:  Kenshi Yamasaki; Richard L Gallo
Journal:  Eur J Dermatol       Date:  2007-12-18       Impact factor: 3.328

Review 8.  The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung disease.

Authors:  J M Sallenave
Journal:  Respir Res       Date:  2000-08-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.